Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$20.56 -0.12 (-0.58%)
As of: Sep 4, 2026 · 3:59 PM EDT

Syndax Pharmaceuticals (SNDX) Property, Plant & Equipment (Net) (2015 - 2026)

Analysis

Syndax Pharmaceuticals (SNDX) Property, Plant & Equipment (Net) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Syndax Pharmaceuticals 1.83 Bn 1.28 Bn 60.67 Mn 212,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 212,000.00
Mar 31, 2026 177,000.00
Dec 31, 2025 181,000.00
Sep 30, 2025 128,000.00
Jun 30, 2024 2,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 8,000.00
Sep 30, 2023 10,000.00
Jun 30, 2023 13,000.00
Mar 31, 2023 17,000.00
Dec 31, 2022 20,000.00
Sep 30, 2022 23,000.00
Jun 30, 2022 256,000.00
Mar 31, 2022 266,000.00
Dec 31, 2021 278,000.00
Sep 30, 2021 158,000.00
Jun 30, 2021 166,000.00
Mar 31, 2021 176,000.00
Dec 31, 2020 192,000.00
Sep 30, 2020 214,000.00